31.10.2023 - Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, announced today . Seite 1
12.09.2023 - Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230911074606/en/Manufacturing Facility for MaaT Pharma’s Microbiome Ecosystem Therapies at Skyepharma’s Skyehub . Seite 1